Alembic Pharma gains after posting stellar Q1 results

Alembic Pharmaceuticals gained 4.75% to Rs 642.45 at 14:20 IST on BSE after consolidated net profit rose 44.63% to Rs 103.75 crore on 25.03% rise in total income to Rs 728.42 crore in Q1 June 2016 over Q1 June 2015.

The result was announced during market hours today, 29 July 2016.

Meanwhile, the BSE Sensex was down 101.05 points, or 0.36% to 28,107.57.

High volumes were witnessed on the counter. On BSE, so far 75,814 shares were traded in the counter, compared with average daily volume of 25,705 shares in the past one quarter. The stock hit a high of Rs 644.50 and a low of Rs 617.60 so far during the day. The stock hit a 52-week high of Rs 757.90 on 29 July 2015. The stock hit a 52-week low of Rs 514.35 on 5 February 2016. The stock had outperformed the market over the past one month till 28 July 2016, rising 13.45% compared with 6.35% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, advancing 0.96% as against Sensex's 10.18% rise.

The large-cap company has an equity capital of Rs 37.70 crore. Face value per share is Rs 2.

Alembic Pharmaceuticals' consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) rose 50% to Rs 156.96 crore in Q1 June 2016 over Q1 June 2015.

Alembic Pharmaceuticals is a vertically integrated pharmaceutical company. It makes active pharmaceutical ingredients and pharmaceutical formulations.

Powered by Capital Market - Live News